Inventor · disambiguated record
Masahiko Mihara
Also filed as: MIHARA MASAHIKO
8 granted patents·6 pending applications·459 citations·filing 1991–2018
89Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD9MIHARA MASAHIKO2CHUGAI SEIYAKU KABUSHIKA KAISHA1KAWAI SHIGETO1OKADA MASAJI1
Top patents by PatentIndex Score
14 records- 0195US5888510AChronic rheumatoid arthritis therapy containing IL-6 antagonist as effective componentCHUGAI PHARMACEUTICAL CO LTD·Filed 1995·Granted Mar 30, 1999·285 cites·11 claims
- 0292US9017677B2Methods of treating a disease mediated by sensitized T cellsMIHARA MASAHIKO·Filed 2006·Granted Apr 28, 2015·20 cites·20 claims
- 0392US8623355B2Methods for suppressing acute rejection of a heart transplantOKADA MASAJI·Filed 2006·Granted Jan 7, 2014·36 cites·20 claims
- 0491US8017121B2Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective componentCHUGAI SEIYAKU KABUSHIKA KAISHA·Filed 2001·Granted Sep 13, 2011·73 cites·3 claims
- 0588US8529895B2Method for suppressing the development of graft-versus-host-disease by administering interleukin 6 receptor antibodiesMIHARA MASAHIKO·Filed 2008·Granted Sep 10, 2013·23 cites·2 claims
- 0665US2009022719A1Preventive and/or therapeutic method for systemic lupus erythematosus comprising anti-IL-6 receptor antibody administrationCHUGAI PHARMACEUTICAL CO LTD·Filed 2008·Application pending·0 cites
- 0758US5354753AMethotrexate derivativeCHUGAI PHARMACEUTICAL CO LTD·Filed 1991·Granted Oct 11, 1994·9 cites·7 claims
- 0858US2002187150A1Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Application pending·0 cites
- 0957US2019002572A1Preventive and/or therapeutic method for systemic lupus erythematosus comprising anti-il-6 receptor antibody administrationCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1056US2005238644A1Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-lL-6 receptor antibody as an active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Application pending·0 cites
- 1155US5958928APharmaceutical agents containing methotrexate derivativeCHUGAI PHARMACEUTICAL CO LTD·Filed 1996·Granted Sep 28, 1999·13 cites·6 claims
- 1254US2017022278A1Preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1353US8603481B2Therapeutic agents for solid tumorsKAWAI SHIGETO·Filed 2004·Granted Dec 10, 2013·0 cites·6 claims
- 1452US2015191540A1Preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masahiko Mihara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →